| __timestamp | ADMA Biologics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 3742367 | 2395000 |
| Thursday, January 1, 2015 | 4311461 | 9057000 |
| Friday, January 1, 2016 | 6360761 | 393000 |
| Sunday, January 1, 2017 | 29164321 | 79309000 |
| Monday, January 1, 2018 | 42194635 | 134428000 |
| Tuesday, January 1, 2019 | 39504238 | 175431000 |
| Wednesday, January 1, 2020 | 61291426 | 124165000 |
| Friday, January 1, 2021 | 79769341 | 121875000 |
| Saturday, January 1, 2022 | 118814535 | 10114000 |
| Sunday, January 1, 2023 | 169273000 | 9206000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for ADMA Biologics, Inc. and Wave Life Sciences Ltd. from 2014 to 2023. Over this period, ADMA Biologics, Inc. has shown a remarkable increase in cost efficiency, with its cost of revenue growing by approximately 4,400%, from $3.7 million in 2014 to $169 million in 2023. In contrast, Wave Life Sciences Ltd. experienced a more volatile trajectory, peaking in 2019 with a cost of revenue of $175 million, before dropping significantly to $9.2 million in 2023. This stark contrast highlights the strategic differences in managing operational costs between the two companies. As the biotech industry continues to evolve, understanding these financial dynamics is crucial for investors and stakeholders alike.
Comparing Cost of Revenue Efficiency: Novartis AG vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for GSK plc and ADMA Biologics, Inc.
Cost of Revenue Trends: GSK plc vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Neurocrine Biosciences, Inc. and ADMA Biologics, Inc.
Cost of Revenue Comparison: Bio-Techne Corporation vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Walgreens Boots Alliance, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Exelixis, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue Trends: Pharming Group N.V. vs ADMA Biologics, Inc.
Analyzing Cost of Revenue: Cytokinetics, Incorporated and ADMA Biologics, Inc.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.